AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
BABA   206.57 (-0.40%)
MU   46.34 (-3.28%)
GE   6.76 (+2.89%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
GILD   75.16 (-3.43%)
DIS   118.77 (+1.25%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

OTCMKTS:TLOGTetralogic Pharmaceuticals Stock Price, Forecast & News

$0.04
+0.02 (+101.52 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.04
Now: $0.04
$0.04
50-Day Range
$0.02
MA: $0.02
$0.03
52-Week Range
$0.02
Now: $0.04
$0.10
Volume700 shs
Average Volume12,914 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta0.93
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Read More
Tetralogic Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:TLOG
Previous SymbolNASDAQ:TLOG
CUSIPN/A
Phone610-889-9900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees29
Next Earnings DateN/A
OptionableNot Optionable

Receive TLOG News and Ratings via Email

Sign-up to receive the latest news and ratings for TLOG and its competitors with MarketBeat's FREE daily newsletter.

Tetralogic Pharmaceuticals (OTCMKTS:TLOG) Frequently Asked Questions

How has Tetralogic Pharmaceuticals' stock been impacted by COVID-19 (Coronavirus)?

Tetralogic Pharmaceuticals' stock was trading at $0.0270 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, TLOG shares have increased by 47.0% and is now trading at $0.0397. View which stocks have been most impacted by Coronavirus.

Has Tetralogic Pharmaceuticals been receiving favorable news coverage?

News stories about TLOG stock have trended extremely negative recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Tetralogic Pharmaceuticals earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned news headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View the latest news aboutTetralogic Pharmaceuticals.

Who are some of Tetralogic Pharmaceuticals' key competitors?

What other stocks do shareholders of Tetralogic Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tetralogic Pharmaceuticals investors own include NovaBay Pharmaceuticals (NBY), NovaBay Pharmaceuticals (NBY), Trevena (TRVN), Vaxart (VXRT), Arrowhead Pharmaceuticals (ARWR), Celgene (CELG), Sangamo Therapeutics (SGMO), Achieve Life Sciences (ACHV), Gilead Sciences (GILD) and GoPro (GPRO).

Who are Tetralogic Pharmaceuticals' key executives?

Tetralogic Pharmaceuticals' management team includes the following people:
  • Dr. Yigong Shi, Co-Founder (Age 52)
  • Sarah E. Frew, Director of Bus. & Commercial Devel.

What is Tetralogic Pharmaceuticals' stock symbol?

Tetralogic Pharmaceuticals trades on the OTCMKTS under the ticker symbol "TLOG."

How do I buy shares of Tetralogic Pharmaceuticals?

Shares of TLOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Tetralogic Pharmaceuticals' stock price today?

One share of TLOG stock can currently be purchased for approximately $0.04.

What is Tetralogic Pharmaceuticals' official website?

The official website for Tetralogic Pharmaceuticals is www.tetralogicpharma.com.

How can I contact Tetralogic Pharmaceuticals?

Tetralogic Pharmaceuticals' mailing address is 343 PHOENIXVILLE PIKE, MALVERN PA, 19355. The biopharmaceutical company can be reached via phone at 610-889-9900 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.